EyePoint Pharmaceuticals
EYPT
EYPT
31 hedge funds and large institutions have $16M invested in EyePoint Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Holders
31
Holding in Top 10
1
Calls
$16K
Puts
$1K
Top Buyers
| 1 | +$10.5M | |
| 2 | +$132K | |
| 3 | +$94K | |
| 4 |
VF
Virtu Financial
New York
|
+$48K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$37K |
Top Sellers
| 1 | -$259K | |
| 2 | -$123K | |
| 3 | -$83.7K | |
| 4 |
FNBT
FineMark National Bank & Trust
Fort Myers,
Florida
|
-$78K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$66.3K |